Showing results (371-380 of 419) with videos related to
Sort By:
Pageof 42
Transplantation|November 27, 2002
Real-time monitoring of acute liver-allograft rejection using the Banff schemaA J Demetris, K Ruppert, I Dvorchik, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 4, 2012
Banff 2011 Meeting report: new concepts in antibody-mediated rejectionM Mengel, B Sis, M Haas, et al.Journal of the American College of Surgeons|April 5, 2005
Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or CampathRon Shapiro, Amit Basu, Henkie Tan, et al.JAMA|January 19, 2012
Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplantsSandy Feng, Udeme D Ekong, Steven J Lobritto, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 14, 2011
Re-examination of the lymphocytotoxic crossmatch in liver transplantation: can C4d stains help in monitoring?J Lunz, K M Ruppert, M M Cajaiba, et al.Hepatology (Baltimore, Md.)|January 17, 2016
A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantationSatoru Todo, Kenichiro Yamashita, Ryoichi Goto, et al.Annals of Surgery|October 8, 2003
Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaningRon Shapiro, Mark L Jordan, Amit Basu, et al.The Journal of Thoracic and Cardiovascular Surgery|April 1, 1996
A prospective trial of tacrolimus (FK 506) in clinical heart transplantation: intermediate-term resultsS M Pham, R L Kormos, B G Hattler, et al.Kidney International|October 15, 2023
Multiple infusions of ex vivo-expanded regulatory T cells promote CD163+ myeloid cells and kidney allograft survival in non-lymphodepleted non-human primatesKazuki Sasaki, Masahiko Kubo, Yu-Chao Wang, et al.Nature Communications|November 17, 2018
Perforin inhibition protects from lethal endothelial damage during fulminant viral hepatitisM Welz, S Eickhoff, Z Abdullah, et al.Pageof 42